📰 Rom News
Page 353 - Rom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.
June 5, 2023
Shares of several cancer drug firms surged in premarket trading on Monday after the companies reported positive clinical trial data from their therapies at an ongoing industry conference in Chicago. ... | June 5, 2023
June 5, 2023
The B marker is removed from the Companys stock short name YANTAI, China, June 5, 2023 /PRNewswire/ -- RemeGen Co., Ltd. , a fully-integrated commercial-stage biotechnology company,... | June 5, 2023
June 5, 2023
Gary Sher, Chief Financial Officer and Board Director of LHV Bank Limited, a subsidiary of AS LHV Group has resigned from his positions with LHV Bank. Mr Sher will remain in his role until 8... | June 5, 2023
June 5, 2023
A leading mineral exploration company in South America, announces that it has entered into an agreement with Geoterra SRL , pursuant to which Latin Metals has purchased from Geoterra , a 100%... | June 5, 2023
June 5, 2023
Issues Statement in Light of Amedisys Disclosure of Unsolicited Proposal from Optum BANNOCKBURN, Ill., June 5, 2023 /PRNewswire/ -- Option Care Health, Inc. today filed with the U.S. Securities... | June 5, 2023
June 5, 2023
Philogen Spa announced Monday that it has bought back 3,290 of its own shares from May 29, 2023 to June 2, 2023. The shares were bought back at an average unit price of EUR15.6863, for a total... | June 5, 2023
June 5, 2023
Tighter lending standards from regional banks are making it harder for U.S. hotel developers to secure funding, slowing construction of new hotels at a time Americans appetite for travel is ripe.... | June 5, 2023
June 5, 2023
The Forum Europeo Digitale is one of the main events of Italy for the promotion of digital media. The 20th edition will be held in Lucca, Italy from June 8th to 9th. ... | June 5, 2023
June 5, 2023
Already positive, the research from UBS and its analyst Sam Arie still consider the stock as a Buy opportunity. The target price remains unchanged at EUR 6.40. | June 5, 2023
June 5, 2023
Elicio Therapeutics Announces Positive Interim Data from the Phase 1 Study of an Investigational Therapeutic Cancer Immunotherapy, ELI-002, in... | June 5, 2023